Metabolic engineering for the production of natural products

Annual Review of Chemical and Biomolecular Engineering

Volumn 2, Issue , 2011, Pages 211-236

  Pickens, Lauren B ^a   Tang, Yi ^a   Chooi, Yit Heng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

combinatorial biosynthesis; secondary metabolism; strain improvement

Indexed keywords

BIOSYNTHETIC PATHWAY; COMBINATORIAL BIOSYNTHESIS; EXPRESSION SYSTEM; FRONT-LINE TREATMENT; HETEROLOGOUS PRODUCTION; METABOLIC ENGINEERING; METABOLIC MODELING; NATURAL PRODUCTS; PATHWAY COMPONENTS; SCIENTIFIC DISCOVERY; SECONDARY METABOLISM; STRAIN IMPROVEMENT; SYSTEMS BIOLOGY;

BIOCHEMISTRY; BIOSYNTHESIS; DRILLING PLATFORMS; GENE ENCODING; GENETIC ENGINEERING; HEALTH CARE; PRODUCTION PLATFORMS;

METABOLISM;

BIOLOGICAL PRODUCT;

BACTERIUM; BIOTECHNOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; FUNGUS; METABOLIC ENGINEERING; METABOLISM; METHODOLOGY; PLANT; PROTEIN ENGINEERING; REVIEW; SYNTHESIS;

BACTERIA; BIOLOGICAL AGENTS; BIOTECHNOLOGY; FUNGI; METABOLIC ENGINEERING; MOLECULAR STRUCTURE; PLANTS; PROTEIN ENGINEERING;

EID: 79959424209     PISSN: 19475438     EISSN: None     Source Type: Journal    
DOI: 10.1146/annurev-chembioeng-061010-114209     Document Type: Article

References (159)

1. Li JWH, Vederas JC. 2009. Drug discovery and natural products: End of an era or an endless frontier? Science 325:161-65
2. Harvey AL. 2008. Natural products in drug discovery. Drug Discov. Today 13:894-901
3. Newman DJ, Cragg GM. 2007. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70:461-77 (Pubitemid 46595760)
4. Dewick PJ. 2009. Medicinal Natural Products: A Biosynthetic Approach.West Sussex, U.K.: Wiley. 3rd ed.
5. Demain AL, Adrio JL. 2008. Contributions of microorganisms to industrial biology. Mol. Biotechnol. 38:41-55
6. Stephanopoulos G, Nielsen J, Aristodou A. 1998. Metabolic Engineering. San Diego: Academic
7. Oberhardt MA, Palsson BO, Papin JA. 2009. Applications of genome-scale metabolic reconstructions. Mol. Syst. Biol. 5:320
8. Savile CK, Janey JM, Mundorff EC,Moore JC, Tam S, et al. 2010. Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture. Science 329:305-9
9. Challis GL,Hopwood DA. 2003. Synergy and contingency as driving forces for the evolution of multiple secondarymetabolite production by Streptomyces species. Proc. Natl. Acad. Sci. USA 100(Suppl. 2):14555-61 (Pubitemid 37499281)
10. Parekh S. 2004. Strain improvement. In The Desk Encyclopedia ofMicrobiology, ed.MSchaechter, pp. 960-73 San Diego: Elsevier Academic
11. Scherlach K, Hertweck C. 2009. Triggering cryptic natural product biosynthesis in microorganisms. Org. Biomol. Chem. 7:1753-60
12. Rokem JS, Lantz AE, Nielsen J. 2007. Systems biology of antibiotic production by microorganisms. Nat. Prod. Rep. 24:1262-87 (Pubitemid 350153625)
13. Berdy J. 2005. Bioactive microbial metabolites. J. Antibiot. 58:1-26
14. Hopwood DA, Kieser T, Bibb M, Buttner M, Chater K. 2000. Practical Streptomyces Genetics. Norwich: John Innes Found.
15. McDaniel R, Ebert-Khosla S, Hopwood DA, Khosla C. 1993. Engineered biosynthesis of novel polyketides. Science 262:1546-50 (Pubitemid 24036782)
16. Ziermann R, Betlach MC. 1999. Recombinant polyketide synthesis in Streptomyces: Engineering of improved host strains. Biotechniques 26:106-10 (Pubitemid 29031576)
17. Penn J, Li X, Whiting A, Latif M, Gibson T, et al. 2006. Heterologous production of daptomycin in Streptomyces lividans. J. Ind. Microbiol. Biotechnol. 33:121-28 (Pubitemid 43104755)
18. Li C, Hazzard C, Florova G, Reynolds KA. 2009. High titer production of tetracenomycins by heterologous expression of the pathway in a Streptomyces cinnamonensis industrial monensin producer strain. Metab. Eng. 11:319-27
19. Pfeifer BA, Admiraal SJ, Gramajo H, Cane DE, Khosla C. 2001. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 291:1790-92 (Pubitemid 32198984)
20. Watanabe K, Rude MA, WalshCT, Khosla C. 2003. Engineered biosynthesis of an ansamycin polyketide precursor in Escherichia coli. Proc. Natl. Acad. Sci. USA 100:9774-78 (Pubitemid 37087017)
21. Peiru S,Menzella HG, Rodriguez E, Carney J, Gramajo H. 2005. Production of the potent antibacterial polyketide erythromycin C in Escherichia coli. Appl. Environ. Microbiol. 71:2539-47 (Pubitemid 40646999)
22. Gruenewald S, Mootz HD, Stehmeier P, Stachelhaus T. 2004. In vivo production of artificial nonribosomal peptide products in the heterologous host Escherichia coli. Appl. Environ. Microbiol. 70:3282-91 (Pubitemid 38745869)
23. Watanabe K, Hotta K, Praseuth AP, Koketsu K, Migita A, et al. 2006. Total biosynthesis of antitumor nonribosomal peptides in Escherichia coli. Nat. Chem. Biol. 2:423-28
24. Mutka SC, Carney JR, Liu Y, Kennedy J. 2006. Heterologous production of epothilone C and D in Escherichia coli. Biochemistry 45:1321-30 (Pubitemid 43167199)
25. Pfeifer BA, Wang CCC, Walsh CT, Khosla C. 2003. Biosynthesis of yersiniabactin, a complex polyketide-nonribosomal peptide, using Escherichia coli as a heterologous host. Appl. Environ. Microbiol. 69:6698-702
26. Baltz RH. 2010. Streptomyces and Saccharopolyspora hosts for heterologous expression of secondary metabolite gene clusters. J. Ind. Microbiol. Biotechnol. 37:759-72
27. Boghigian BA, Pfeifer BA. 2008. Current status, strategies, and potential for the metabolic engineering of heterologous polyketides in Escherichia coli. Biotechnol. Lett. 30:1323-30
28. Challis GL. 2006. Engineering Escherichia coli to produce nonribosomal peptide antibiotics. Nat. Chem. Biol. 2:398-400 (Pubitemid 44114914)
29. ZhangH, Wang Y, Pfeifer BA. 2008. Bacterial hosts for natural product production. Mol. Pharm. 5:212-25 (Pubitemid 351579125)
30. Hoffmeister D, Keller NP. 2007. Natural products of filamentous fungi: Enzymes, genes, and their regulation. Nat. Prod. Rep. 24:393-416 (Pubitemid 46496563)
31. Manzoni M, Rollini M. 2002. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl. Microbiol. Biotechnol. 58:555-64 (Pubitemid 34299219)
32. Lubertozzi D, Keasling JD. 2009. Developing Aspergillus as a host for heterologous expression. Biotechnol. Adv. 27:53-75
33. Bedford DJ, Schweizer E, Hopwood DA, Khosla C. 1995. Expression of a functional fungal polyketide synthase in the bacterium Streptomyces coelicolor A3(2). J. Bacteriol. 177:4544-48
34. Kealey JT, Liu L, Santi DV, Betlach MC, Barr PJ. 1998. Production of a polyketide natural product in nonpolyketide-producing prokaryotic and eukaryotic hosts. Proc. Natl. Acad. Sci. USA 95:505-9 (Pubitemid 28083772)
35. Fujii I, Ono Y, Tada H, Gomi K, Ebizuka Y, et al. 1996. Cloning of the polyketide synthase gene atX from Aspergillus terreus and its identification as the 6-methylsalicylic acid synthase gene by heterologous expression. Mol. Gen. Genet. 253:1-10 (Pubitemid 26419981)
36. Xu Y, Orozco R, Wijeratne EMK, Gunatilaka AAL, Stock SP, et al. 2008. Biosynthesis of the cyclooligomer depsipeptide beauvericin, a virulence factor of the entomopathogenic fungus Beauveria bassiana. Chem. Biol. 15:898-907
37. Heneghan MN, Yakasai AA, Halo LM, Song Z, Bailey AM, et al. 2010. First heterologous reconstruction of a complete functional fungal biosynthetic multigene cluster. ChemBioChem 11:1508-12
38. Ma SM, Li JWH, Choi JW, Zhou H, Lee KKM, et al. 2009. Complete reconstitution of a highly reducing iterative polyketide synthase. Science 326:589-92
39. Schümann J, Hertweck C. 2006. Advances in cloning, functional analysis and heterologous expression of fungal polyketide synthase genes. J. Biotechnol. 124:690-703 (Pubitemid 44066598)
40. Schneider P, Misiek M, HoffmeisterD. 2008. In vivo and in vitro production options for fungal secondary metabolites. Mol. Pharm. 5:234-42 (Pubitemid 351579127)
41. Huang Q, Roessner CA, Croteau R, Scott AI. 2001. Engineering Escherichia coli for the synthesis of taxadiene, a key intermediate in the biosynthesis of taxol. Bioorg. Med. Chem. 9:2237-42 (Pubitemid 32834614)
42. Engels B, Dahm P, Jennewein S. 2008. Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production. Metab. Eng. 10:201-6
43. Ajikumar PK, Xiao W-H, Tyo KEJ, Wang Y, Simeon F, et al. 2010. Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli. Science 330:70-74
44. Martin VJJ, Pitera DJ, Withers ST, Newman JD, Keasling JD. 2003. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat. Biotechnol. 21:796-802 (Pubitemid 36791399)
45. Ro D-K, Paradise EM, Ouellet M, Fisher KJ, Newman KL, et al. 2006. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440:940-43
46. Minami H, Kim J-S, Ikezawa N, Takemura T, Katayama T, et al. 2008. Microbial production of plant benzylisoquinoline alkaloids. Proc. Natl. Acad. Sci. USA 105:7393-98 (Pubitemid 351830028)
47. Hawkins KM, Smolke CD. 2008. Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae. Nat. Chem. Biol. 4:564-73
48. Horinouchi S. 2009. Combinatorial biosynthesis of plant medicinal polyketides by microorganisms. Curr. Opin. Chem. Biol. 13:197-204
49. Miyahisa I, Kaneko M, Funa N, Kawasaki H, Kojima H, et al. 2007. Efficient production of (2 S)- flavanones by Escherichia coli containing an artificial biosynthetic gene cluster. Appl. Microbiol. Biotechnol. 68:498-504 (Pubitemid 41549994)
50. Gillam EMJ. 2008. Engineering cytochrome P450 enzymes. Chem. Res. Toxicol. 21:220-31 (Pubitemid 351219720)
51. Leonard E, Koffas MAG. 2007. Engineering of artificial plant cytochrome P450 enzymes for synthesis of isoflavones by Escherichia coli. Appl. Environ. Microbiol. 73:7246-51 (Pubitemid 350196674)
52. Chang MCY, Eachus RA, Trieu W, Ro D-K, Keasling JD. 2007. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat. Chem. Biol. 3:274-77 (Pubitemid 46625834)
53. Ryu Y-G, Butler MJ, Chater KF, Lee KJ. 2006. Engineering of primary carbohydrate metabolism for increased production of actinorhodin in Streptomyces coelicolor. Appl. Environ. Microbiol. 72:7132-39 (Pubitemid 44748426)
54. ZhaW, Rubin-Pitel SB, Shao Z, Zhao H. 2009. Improving cellular malonyl-CoA level in Escherichia coli via metabolic engineering. Metab. Eng. 11:192-98
55. Fowler ZL, GikandiWW,Koffas MAG. 2009. Increasedmalonyl coenzyme A biosynthesis by tuning the Escherichia coli metabolic network and its application to flavanone production. Appl. Environ. Microbiol. 75:5831-39
56. Cropp A, Chen S, Liu H, Zhang W, Reynolds KA. 2001. Genetic approaches for controlling ratios of related polyketide products in fermentation processes. J. Ind. Microbiol. Biotechnol. 27:368-77 (Pubitemid 34043005)
57. Reeves AR, Brikun IA, Cernota WH, Leach BI, Gonzalez MC, et al. 2007. Engineering of the methylmalonyl-CoA metabolite node of Saccharopolyspora erythraea for increased erythromycin production. Metab. Eng. 9:293-303 (Pubitemid 46809527)
58. Han SJ, Park SW, Kim BW, Sim SJ. 2008. Selective production of epothilone B by heterologous expression of propionyl-CoA synthetase in Sorangium cellulosum. J. Microbiol. Biotechnol. 18:135-37
59. Kuzuyama T. 2002. Mevalonate and nonmevalonate pathways for the biosynthesis of isoprene units. Biosci. Biotechnol. Biochem. 66:1619-27 (Pubitemid 39246817)
60. Farmer WR, Liao JC. 2001. Precursor balancing for metabolic engineering of lycopene production in Escherichia coli. Biotechnol. Prog. 17:57-61 (Pubitemid 32145375)
61. Kajiwara S, Fraser PD, Kondo K, Misawa N. 1997. Expression of an exogenous isopentenyl diphosphate isomerase gene enhances isoprenoid biosynthesis in Escherichia coli. Biochem. J. 324:421-26 (Pubitemid 27267983)
62. Kim SW, Keasling JD. 2001. Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway in Escherichia coli enhances lycopene production. Biotechnol. Bioeng. 72:408-15
63. Pitera DJ, Paddon CJ, Newman JD, Keasling JD. 2007. Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab. Eng. 9:193-207 (Pubitemid 46329511)
64. Shiba Y, Paradise EM, Kirby J, Ro D-K, Keasling JD. 2007. Engineering of the pyruvate dehydrogenase bypass in Saccharomyces cerevisiae for high-level production of isoprenoids. Metab. Eng. 9:160-68 (Pubitemid 46331877)
65. Knaggs AR. 1999. The biosynthesis of shikimate metabolites. Nat. Prod. Rep. 16:525-60 (Pubitemid 29395701)
66. Thykaer J, Nielsen J, Wohlleben W, Weber T, Gutknecht M, et al. 2010. Increased glycopeptide production after overexpression of shikimate pathway genes being part of the balhimycin biosynthetic gene cluster. Metab. Eng. 12:455-61
67. Yanai K, Murakami T, Bibb M. 2006. Amplification of the entire kanamycin biosynthetic gene cluster during empirical strain improvement of Streptomyces kanamyceticus. Proc.Natl. Acad. Sci.USA103:9661-66 (Pubitemid 43955881)
68. Smith DJ, Bull JH, Edwards J, Turner G. 1989. Amplification of the isopenicillin N synthetase gene in a strain of Penicillium chrysogenum producing high levels of penicillin. Mol. Gen. Genet. 216:492-97 (Pubitemid 19117843)
69. PeschkeU, Schmidt H, ZhangHZ, PiepersbergW. 1995. Molecular characterization of the lincomycinproduction gene cluster of Streptomyces lincolnensis 78-11. Mol. Microbiol. 16:1137-56
70. Anthony JR, Anthony LC, Nowroozi F, Kwon G, Newman JD, et al. 2009. Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene. Metab. Eng. 11:13-19
71. Keasling JD. 1999. Gene-expression tools for the metabolic engineering of bacteria. Trends Biotechnol. 17:452-60 (Pubitemid 29467492)
72. Leonard E, Ajikumar PK, Thayer K, Xiao W-H, Mo JD, et al. 2010. Combining metabolic and protein engineering of a terpenoid biosynthetic pathway for overproduction and selectivity control. Proc. Natl. Acad. Sci. USA 107:13654-59
73. Kennedy J, Turner G. 1996. δ-(L-α-Aminoadipyl)-L-cysteinyl-D- valine synthetase is a rate limiting enzyme for penicillin production in Aspergillus nidulans. Mol. Gen. Genet. 253:189-97 (Pubitemid 26420004)
74. Fernández-Cañón JM, Peñalva MA. 1995. Overexpression of two penicillin structural genes in Aspergillus nidulans. Mol. Gen. Genet. 246:110-18
75. Veenstra AE, van Solingen P, Bovenberg RAL, van der Voort LHM. 1991. Strain improvement of Penicillium chrysogenum by recombinant DNA techniques. J. Biotechnol. 17:81-90
76. Malla S, Niraula NP, Liou K, Sohng JK. 2009. Enhancement of doxorubicin production by expression of structural sugar biosynthesis and glycosyltransferase genes in Streptomyces peucetius. J. Biosci. Bioeng. 108:92-98
77. Malla S, Niraula NP, Liou K, Sohng JK. 2010. Self-resistance mechanism in Streptomyces peucetius: Overexpression of drrA, drrB and drrC for doxorubicin enhancement. Microbiol. Res. 165:259-67
78. Chen Y, SmanskiM, Shen B. 2010. Improvement of secondary metabolite production in Streptomyces by manipulating pathway regulation. Appl. Microbiol. Biotechnol. 86:19-25
79. Chen Y, Wendt-Pienkowski E, Shen B. 2008. Identification and utility of FdmR1 as a Streptomyces antibiotic regulatory protein activator for fredericamycin production in Streptomyces griseus ATCC 49344 and heterologous hosts. J. Bacteriol. 190:5587-96
80. Lombo F, Brana AF, Mendez C, Salas JA. 1999. The mithramycin gene cluster of Streptomyces argillaceus contains a positive regulatory gene and two repeated DNA sequences that are located at both ends of the cluster. J. Bacteriol. 181:642-47 (Pubitemid 29045158)
81. Sakai K, Kinoshita H, Shimizu T, Nihira T. 2008. Construction of a citrinin gene cluster expression system in heterologous Aspergillus oryzae. J. Biosci. Bioeng. 106:466-72
82. Bergmann S, Schumann J, Scherlach K, Lange C, Brakhage AA, et al. 2007. Genomics-driven discovery of PKS-NRPS hybrid metabolites from Aspergillus nidulans. Nat. Chem. Biol. 3:213-17 (Pubitemid 46440540)
83. Chiang YM, Szewczyk E, Davidson AD, Keller N, Oakley BR, et al. 2009. A gene cluster containing two fungal polyketide synthases encodes the biosynthetic pathway for a polyketide, asperfuranone, in Aspergillus nidulans. J. Am. Chem. Soc. 131:2965-70
84. Smanski MJ, Peterson RM, Rajski SR, Shen B. 2009. Engineered Streptomyces platensis strains that overproduce antibiotics platensimycin and platencin. Antimicrob. Agents Chemother. 53:1299-304
85. Alper H, Fischer C, Nevoigt E, Stephanopoulos G. 2005. Tuning genetic control through promoter engineering. Proc. Natl. Acad. Sci. USA 102:12678-83 (Pubitemid 41279425)
86. Nevoigt E, Kohnke J, Fischer CR, Alper H, Stahl U, et al. 2006. Engineering of promoter replacement cassettes for fine-tuning of gene expression in Saccharomyces cerevisiae. Appl. Environ. Microbiol. 72:5266-73
87. Pfleger BF, Pitera DJ, Smolke CD, Keasling JD. 2006. Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes. Nat. Biotechnol. 24:1027-32 (Pubitemid 44215398)
88. Salis HM,Mirsky EA, Voigt CA. 2009. Automated design of synthetic ribosome binding sites to control protein expression. Nat. Biotechnol. 27:946-50
89. Kizer L, Pitera DJ, Pfleger BF, Keasling JD. 2008. Application of functional genomics to pathway optimization for increased isoprenoid production. Appl. Environ. Microbiol. 74:3229-41 (Pubitemid 351747029)
90. FoxRJ, HuismanGW.2008. Enzyme optimization: Moving from blind evolution to statistical exploration of sequence function space. Trends Biotechnol. 26:132-38
91. Wang C-w, Oh M-K, Liao JC. 2000. Directed evolution of metabolically engineered Escherichia coli for carotenoid production. Biotechnol. Prog. 16:922-26 (Pubitemid 32044842)
92. Paradise EM, Kirby J, Chan R, Keasling JD. 2008. Redirection of flux through the FPP branch-point in Saccharomyces cerevisiae by down-regulating squalene synthase. Biotechnol. Bioeng. 100:371-78 (Pubitemid 351758178)
93. Xie X, Wong WW, Tang Y. 2007. Improving simvastatin bioconversion in Escherichia coli by deletion of bioH. Metab. Eng. 9:379-86 (Pubitemid 47102688)
94. Lomovskaya N, Otten SL, Doi-Katayama Y, Fonstein L, Liu X-C, et al. 1999. Doxorubicin overproduction in Streptomyces peucetius: Cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene. J. Bacteriol. 181:305-18 (Pubitemid 29013685)
95. Chemler JA, Fowler ZL, McHugh KP, Koffas MAG. 2010. Improving NADPH availability for natural product biosynthesis in Escherichia coli by metabolic engineering. Metab. Eng. 12:96-104
96. Sung BH, Lee JH, Kim SC. 2009. Escherichia coli genome engineering and minimization for the construction of a bioengine. In Systems Biology and Biotechnology of Escherichia coli, ed. SY Lee, pp. 19-40. London: Springer Science + Business Media
97. Komatsu M, Uchiyama T, Omura S, Cane DE, Ikeda H. 2010. Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism. Proc. Natl. Acad. Sci. USA 107:2646-51
98. Floss HG. 2006. Combinatorial biosynthesis-potential and problems. J. Biotechnol. 124:242-57 (Pubitemid 43816127)
99. Baltz RH. 2006. Molecular engineering approaches to peptide, polyketide and other antibiotics. Nat. Biotechnol. 24:1533-40 (Pubitemid 44967477)
100. Madduri K, Kennedy J, Rivola G, Inventi-Solari A, Filippini S, et al. 1998. Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius. Nat. Biotechnol. 16:69-74
101. Fischbach MA, Walsh CT, Clardy J. 2008. The evolution of gene collectives: How natural selection drives chemical innovation. Proc. Natl. Acad. Sci. USA 105:4601-8 (Pubitemid 351753784)
102. Mendes M, Recio E, Fouces R, LuitenR,Martin J, et al. 2001. Engineered biosynthesis of novel polyenes: A pimaricin derivative produced by targeted gene disruption in Streptomyces natalensis. Chem. Biol. 8:635-44 (Pubitemid 32632531)
103. Remsing LL, Gonzalez AM, Nur-e-Alam M, Fernandez-LozanoMJ, Brana AF, et al. 2003. Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosylmithramycin SK: Three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis. J. Am. Chem. Soc. 125:5745-53 (Pubitemid 36592899)
104. Ito T, RoongsawangN, Shirasaka N, Lu W, Flatt PM, et al. 2009. Deciphering pactamycin biosynthesis and engineered production of new pactamycin analogues. ChemBioChem 10:2253-65
105. Ju J, Li W, Yuan Q, Peters NR, Hoffmann FM, et al. 2009. Functional characterization of ttmM unveils new tautomycin analogs and insight into tautomycin biosynthesis and activity. Org. Lett. 11:1639-42
106. Zhang M-Q, Gaisser S, Nur-E-Alam M, Sheehan LS, Vousden WA, et al. 2008. Optimizing natural products by biosynthetic engineering: Discovery of nonquinone Hsp90 inhibitors. J. Med. Chem. 51:5494-97
107. Tang L, Chung L,Carney JR, Starks CM, Licari P, et al. 2005. Generation of new epothilones by genetic engineering of a polyketide synthase in Myxococcus xanthus. J. Antibiot. 58:178-84
108. Power P, Dunne T, Murphy B, Nic Lochlainn L, Rai D, et al. 2008. Engineered synthesis of 7-oxoand 15-deoxy-15-oxo-amphotericins: Insights into structure-activity relationships in polyene antibiotics. Chem. Biol. 15:78-86
109. Khaw L, Bohm G, Metcalfe S, Staunton J, Leadlay P. 1998. Mutational biosynthesis of novel rapamycins by a strain of Streptomyces hygroscopicus NRRL 5491 disrupted in rapL, encoding a putative lysine cyclodeaminase. J. Bacteriol. 180:809-14 (Pubitemid 28084204)
110. Weist S, Bister B, Puk O, Bischoff D, Pelzer S, et al. 2002. Fluorobalhimycin-a new chapter in glycopeptide antibiotic research. Angew. Chem. Int. Ed. 41:3383-85 (Pubitemid 35230632)
111. Galm U, DessoyMA, Schmidt J,Wessjohann LA, Heide L. 2004. In vitro and in vivo production of new aminocoumarins by a combined biochemical, genetic, and synthetic approach. Chem. Biol. 11:173-83 (Pubitemid 38300288)
112. Li SM,Heide L. 2005. New aminocoumarin antibiotics from genetically engineered Streptomyces strains. Curr. Med. Chem. 12:419-27 (Pubitemid 40305629)
113. Kim W, Lee JS, Lee D, Cai XF, Shin JC, et al. 2007. Mutasynthesis of geldanamycin by the disruption of a gene producing starter unit: Generation of structural diversity at the benzoquinone ring. ChemBioChem 8:1491-94 (Pubitemid 47436903)
114. Menzella HG, Tran TT, Carney JR, Lau-Wee J, Galazzo J, et al. 2009. Potent non-benzoquinone ansamycin heat shock protein 90 inhibitors from genetic engineering of Streptomyces hygroscopicus. J. Med. Chem. 52:1518-21
115. EustaquioAS, MooreBS. 2008. Mutasynthesis of fluorosalinosporamide, a potent and reversible inhibitor of the proteasome. Angew. Chem. Int. Ed. 47:3936-38
116. Eustáquio A, O'Hagan D, Moore B. 2010. Engineering fluorometabolite production: Fluorinase expression in Salinispora tropica yields fluorosalinosporamide. J. Nat. Prod. 73:378-82
117. Runguphan W, Maresh JJ, O'Connor SE. 2009. Silencing of tryptamine biosynthesis for production of nonnatural alkaloids in plant culture. Proc. Natl. Acad. Sci. USA 106:13673-78
118. WeissmanKJ. 2007. Mutasynthesis-uniting chemistry and genetics for drug discovery. Trends Biotechnol. 25:139-42 (Pubitemid 46413365)
119. Hopwood DA, Malpartida F, Kieser HM, Ikeda H, Duncan J, et al. 1985. Production of "hybrid" antibiotics by genetic engineering. Nature 314:642-44 (Pubitemid 15080845)
120. de Boer AL, Schmidt-Dannert C. 2003. Recent efforts in engineering microbial cells to produce new chemical compounds. Curr. Opin. Chem. Biol. 7:273-78 (Pubitemid 36514959)
121. Challis GL. 2008. Genome mining for novel natural product discovery. J. Med. Chem. 51:2618-28 (Pubitemid 351620782)
122. Pfeifer BA, Khosla C. 2001. Biosynthesis of polyketides in heterologous hosts. Microbiol. Mol. Biol. Rev. 65:106-18 (Pubitemid 32204289)
123. Cane DE, Walsh CT, Khosla C. 1998. Harnessing the biosynthetic code: Combinations, permutations, and mutations. Science 282:63-68 (Pubitemid 28471127)
124. Moyne AL, Cleveland TE, Tuzun S. 2004. Molecular characterization and analysis of the operon encoding the antifungal lipopeptide bacillomycin D. FEMS Microbiol. Lett. 234:43-49 (Pubitemid 38515749)
125. Reeves CD, Ward SL, Revill WP, Suzuki H, Marcus M, et al. 2004. Production of hybrid 16-membered macrolides by expressing combinations of polyketide synthase genes in engineered Streptomyces fradiae hosts. Chem. Biol. 11:1465-72 (Pubitemid 39351382)
126. McDaniel R, Thamchaipenet A, Gustafsson C, Fu H, Betlach M, et al. 1999. Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel "unnatural" natural products. Proc. Natl. Acad. Sci. USA 96:1846-51 (Pubitemid 29117830)
127. Rascher A, Hu ZH, Viswanathan N, Schirmer A, Reid R, et al. 2003. Cloning and characterization of a gene cluster for geldanamycin production in Streptomyces hygroscopicus NRRL 3602. FEMS Microbiol. Lett. 218:223-30 (Pubitemid 36183500)
128. Patel K, Piagentini M, Rascher A, Tian ZQ, Buchanan GO, et al. 2004. Engineered biosynthesis of geldanamycin analogs for Hsp90 inhibition. Chem. Biol. 11:1625-33 (Pubitemid 39651296)
129. Gaisser S, Kellenberger L, Kaja AL, Weston AJ, Lill RE, et al. 2003. Direct production of ivermectinlike drugs after domain exchange in the avermectin polyketide synthase of Streptomyces avermitilis ATCC31272. Org. Biomol. Chem. 1:2840-47
130. Miao V, Coeffet-Le GalMF, Nguyen K, Brian P, Penn J, et al. 2006. Genetic engineering in Streptomyces roseosporus to produce hybrid lipopeptide antibiotics. Chem. Biol. 13:269-76
131. Nguyen KT, Ritz D, Gu JQ, Alexander D, Chu M, et al. 2006. Combinatorial biosynthesis of novel antibiotics related to daptomycin. Proc. Natl. Acad. Sci. USA 103:17462-67 (Pubitemid 44788991)
132. Coeffet-Le Gal MF, Thurston L, Rich P, Miao V, Baltz RH. 2006. Complementation of daptomycin dptA and dptD deletion mutations in trans and production of hybrid lipopeptide antibiotics. Microbiology 152:2993-3001 (Pubitemid 44542380)
133. Nguyen KT, He XW, Alexander DC, Li C, Gu JQ, et al. 2010. Genetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties. Antimicrob. Agents Chemother. 54:1404-13
134. Rodriguez E, McDaniel R. 2001. Combinatorial biosynthesis of antimicrobials and other natural products. Curr. Opin. Microbiol. 4:526-34 (Pubitemid 32964100)
135. Baltz RH. 2009. Daptomycin: Mechanisms of action and resistance, and biosynthetic engineering. Curr. Opin. Chem. Biol. 13:144-51
136. Park SR, Han AR, Ban YH, Yoo YJ, Kim EJ, et al. 2010. Genetic engineering of macrolide biosynthesis: Past advances, current state, and future prospects. Appl. Environ. Microbiol. 85:1227-39
137. Strieker M, Marahiel MA. 2009. The structural diversity of acidic lipopeptide antibiotics. ChemBioChem 10:607-16
138. Weissman KJ, Leadlay PF. 2005. Combinatorial biosynthesis of reduced polyketides. Nat. Rev. Microbiol. 3:925-36 (Pubitemid 43078156)
139. Mendez C, Salas JA. 2001. Altering the glycosylation pattern of bioactive compounds. Trends Biotechnol. 19:449-56 (Pubitemid 32972072)
140. Luzhetskyy A, Bechthold A. 2005. It works: Combinatorial biosynthesis for generating novel glycosylated compounds. Mol. Microbiol. 58:3-5 (Pubitemid 41415026)
141. Olano C, Mendez C, Salas JA. 2010. Post-PKS tailoring steps in natural product-producing actinomycetes from the perspective of combinatorial biosynthesis. Nat. Prod. Rep. 27:571-616
142. Flatman RH, Eustaquio A, Li SM, Heide L, Maxwell A. 2006. Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinatorial biosynthesis. Antimicrob. Agents Chemother. 50:1136-42
143. Sanchez C, Zhu LL, Brana AF, Salas AP, Rohr J, et al. 2005. Combinatorial biosynthesis of antitumor indolocarbazole compounds. Proc. Natl. Acad. Sci. USA 102:461-66 (Pubitemid 40116789)
144. Sanchez C, Salas AP, Brana AF, Palomino M, Pineda-Lucena A, et al. 2009. Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles. Chem. Commun. 2009:4118-20
145. Werneburg M, Busch B, He J, Richter ME, Xiang L, et al. 2010. Exploiting enzymatic promiscuity to engineer a focused library of highly selective antifungal and antiproliferative aureothin analogues. J. Am. Chem. Soc. 132:10407-13
146. Horinouchi S. 2008. Combinatorial biosynthesis of non-bacterial and unnatural flavonoids, stilbenoids and curcuminoids by microorganisms. J. Antibiot. 61:709-28
147. Katsuyama Y, Funa N, Miyahisa I, Horinouchi S. 2007. Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli. Chem. Biol. 14:613-21 (Pubitemid 46920981)
148. Leonard E, Runguphan W, O'Connor S, Prather KJ. 2009. Opportunities in metabolic engineering to facilitate scalable alkaloid production. Nat. Chem. Biol. 5:292-300
149. Runguphan W, Qu X, O'Connor SE. 2010. Integrating carbon-halogen bond formation into medicinal plant metabolism. Nature 468:461-64.
150. Williams GJ, Goff RD, Zhang C, Thorson JS. 2008. Optimizing glycosyltransferase specificity via "hot spot" saturation mutagenesis presents a catalyst for novobiocin glycorandomization. Chem. Biol. 15:393-401 (Pubitemid 351512342)
151. Williams GJ, Zhang C, Thorson JS. 2007. Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution. Nat. Chem. Biol. 3:657-62 (Pubitemid 47417707)
152. Chen S, Galan MC, Coltharp C, O'Connor SE. 2006. Redesign of a central enzyme in alkaloid biosynthesis. Chem. Biol. 13:1137-41 (Pubitemid 44750736)
153. Runguphan W, O'Connor SE. 2009. Metabolic reprogramming of periwinkle plant culture. Nat. Chem. Biol. 5:151-53
154. Schmidt-Dannert C, Umeno D, Arnold FH. 2000. Molecular breeding of carotenoid biosynthetic pathways. Nat. Biotechnol. 18:750-53 (Pubitemid 30460691)
155. Yoshikuni Y, Ferrin TE, Keasling JD. 2006. Designed divergent evolution of enzyme function. Nature 440:1078-82
156. Hans M, Hornung A, Dziarnowski A, Cane DE, Khosla C. 2003. Mechanistic analysis of acyl transferase domain exchange in polyketide synthase modules. J. Am. Chem. Soc. 125:5366-74 (Pubitemid 36582745)
157. Hunziker D, Yu TW, Hutchinson CR, Floss HG, Khosla C. 1998. Primer unit specificity in rifamycin biosynthesis principally resides in the later stages of the biosynthetic pathways. J. Am. Chem. Soc. 120:1092-93 (Pubitemid 28089916)
158. Zhou Z, Lai JR, Walsh CT. 2007. Directed evolution of aryl carrier proteins in the enterobactin synthetase. Proc. Natl. Acad. Sci. USA 104:11621-26 (Pubitemid 47175062)
159. Fischbach MA, Lai JR, Roche ED, Walsh CT, Liu DR. 2007. Directed evolution can rapidly improve the activity of chimeric assembly-line enzymes. Proc. Natl. Acad. Sci. USA 104:11951-56 (Pubitemid 47185611)